April 18, 2014 2:31 PM ET

Biotechnology

Company Overview of VLST Corporation

Company Overview

VLST Corporation, a biotechnology company, discovers and develops therapeutics for the treatment of inflammatory and autoimmune disorders. The company provides VLST-007 (hCD47-hFc), a dimeric protein for the treatment of inflammatory and autoimmune diseases; VLST-002 (AntiKine Ab) multi-reactive anti-chemokine antibodies for the treatment of autoimmune and inflammatory diseases; and Hepatitis C virus antiviral products. Its discovery platform has primary applications for the treatment of inflammatory and autoimmune diseases such as rheumatoid arthritis, Crohn’s disease, multiple sclerosis, lupus, and diabetes. The company was founded in 2004 and is headquartered in Seattle, Washington.

307 Westlake Avenue North

Suite 300

Seattle, WA 98109

United States

Founded in 2004

Phone:

206-262-5500

Fax:

206-262-5599

Key Executives for VLST Corporation

Chief Executive Officer
Age: 55
Executive Chairman
Age: 49
Co-Founder and Chairman of the Scientific Advisory Board
Vice President of Finance & Administration
Compensation as of Fiscal Year 2013.

VLST Corporation Key Developments

VLST Corporation Announces In-Licensing Agreement with Pfizer Inc. for Anti-CD40 Monoclonal Antibody

VLST Corporation announced an in-licensing agreement with Pfizer Inc. for an anti-CD40 monoclonal antibody. CP-870,893 is a potent CD40 agonist that has been evaluated in a number of preclinical and clinical trials to date. These studies have determined the safety profile, pharmacokinetics and pharmacodynamic parameters of CD40-mediated immune activation as well as the maximum tolerated dose of the antibody. VLST plans to advance this compound into efficacy studies in an oncology setting. VLST is currently evaluating multiple clinical opportunities. Under the terms of the agreement, Pfizer will retain co-exclusive rights to CP-870,893 in the oncology vaccine field.

Similar Private Companies By Industry

Company Name Region
Genovics United States
Antigen Laboratories, Inc. United States
Integrated Genetics United States
Aseptica, Inc. United States
Simibio United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VLST Corporation, please visit www.vlstcorp.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.